These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 3983594)

  • 1. [Does dipyridamole (Persantin) have antithrombotic action?].
    Loeliger EA
    Schweiz Med Wochenschr; 1985 Feb; 115(7):252-3. PubMed ID: 3983594
    [No Abstract]   [Full Text] [Related]  

  • 2. [The antithrombotic action of oral anticoagulants, acetylsalicylic acid (Aspirin) and dipyridamole (Persantin)].
    Loeliger EA
    Ned Tijdschr Geneeskd; 1984 Oct; 128(43):2047-9. PubMed ID: 6390223
    [No Abstract]   [Full Text] [Related]  

  • 3. Antithrombotic therapy.
    Kazmier FJ
    Cardiovasc Clin; 1983; 13(2):321-33. PubMed ID: 6839327
    [No Abstract]   [Full Text] [Related]  

  • 4. Dipyridamole--evaluation of an established antithrombotic drug in view of modern concepts of blood cell-vessel wall interactions.
    Eisert WG; Müller TH
    Thromb Res Suppl; 1990; 12():65-72. PubMed ID: 2082490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antithrombotic effect of dipyridamole].
    Aznar J; García-Conde Brú J; Díaz MC
    Rev Clin Esp; 1968 May; 109(4):345-8. PubMed ID: 5710438
    [No Abstract]   [Full Text] [Related]  

  • 6. Dipyridamole.
    FitzGerald GA
    N Engl J Med; 1987 May; 316(20):1247-57. PubMed ID: 3553945
    [No Abstract]   [Full Text] [Related]  

  • 7. ["Does dipyridamole (Persantin) possess antithrombotic activity?"].
    Guittard C; Odavic R
    Schweiz Med Wochenschr; 1985 Aug; 115(31-32):1107-9. PubMed ID: 4048908
    [No Abstract]   [Full Text] [Related]  

  • 8. Letter: Clinical and experimental effects of dipyridamole.
    Coeugniet E
    Thromb Res; 1975 Jul; 7(1):251-2. PubMed ID: 807988
    [No Abstract]   [Full Text] [Related]  

  • 9. [Persantin: coronary insufficiency, prevention of thrombosis, kidney failure, intrauterine asphyxia].
    Heynen U
    Z Allgemeinmed; 1972 Feb; 48(5):246-50. PubMed ID: 5063268
    [No Abstract]   [Full Text] [Related]  

  • 10. [The antithrombotic effect of dipyridamole and acetylsalicylic acid. A prospective clinical examination].
    Harjola PT; Meurala H
    Med Welt; 1981 Jul; 32(30-31):1178. PubMed ID: 7024707
    [No Abstract]   [Full Text] [Related]  

  • 11. Factor Xa is a superior target to factor IIa for antithrombotic therapies.
    Büller HR
    Semin Thromb Hemost; 2003 Dec; 29 Suppl 1():37. PubMed ID: 14730477
    [No Abstract]   [Full Text] [Related]  

  • 12. Antithrombotic effects of drugs which suppress platelet function: their potential in prevention growth of tumour cells.
    Turpie AG
    Prog Clin Biol Res; 1982; 89():31-62. PubMed ID: 7051035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the site of action of persantin, segontin and trimanyl. Their effect on the bioelectric activity of rabbit's brain.
    Janicki K; Trabka J; Gatarski J
    Pol Med J; 1970; 9(1):1816. PubMed ID: 5437035
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparative study of 2 antithrombotic regimens in 75 patients with coronary endoprostheses].
    Iturbe T; Sánchez C; Moreno JA; Olave T; Azaceta G; Varo MJ; Civeira E; Peleato J; Cornudella R
    Sangre (Barc); 1997 Oct; 42(5):387-90. PubMed ID: 9424739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dipyridamole as an antithrombotic drug.
    Loeliger EA
    N Engl J Med; 1988 Oct; 319(14):951-2. PubMed ID: 3419462
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prophylaxis of thrombogenesis in the diabetic patient].
    Zurro Hernández J; Arribas Castrillo JM; Durán García S; Quintero de Juana A; Romero E
    Rev Clin Esp; 1974 Sep; 134(5):473-7. PubMed ID: 4438743
    [No Abstract]   [Full Text] [Related]  

  • 17. In vivo study of bleeding and antithrombotic effects of low molecular weight heparin ML-009723.
    Malinowska K; Iqbal O; Hoppensteadt DA; Walenga JM; Fareed J
    Semin Thromb Hemost; 1993; 19 Suppl 1():58-62. PubMed ID: 8395732
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hyperaggregation effects of thrombolytic enzymes].
    Brochier M; Griguer P
    Therapeutique; 1973 Nov; 49(9):565-6. PubMed ID: 4792901
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of endothelium in antithrombotic effect of the renin-angiotensin system blockade.
    Buczko W; Matys T; Kucharewicz I; Chabielska E
    J Physiol Pharmacol; 1999 Dec; 50(4):499-507. PubMed ID: 10639001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hemodynamic effects of dipyridamole (Persantin) following beta-blockade in coronary failure].
    Kinsbergen M; Friedemann M
    Schweiz Med Wochenschr; 1973 Feb; 103(8):312-5. PubMed ID: 4144418
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.